Search

Displaying results 4581 - 4587 of 4587 in total
  1. Drug

    Diphenadione

    go.drugbank.com/drugs/DB13347
    Experimental

    Categories: Vitamin K Antagonists
  2. Drug

    XL281

    go.drugbank.com/drugs/DB05190
    Investigational

    XL281 is a novel anticancer compound designed to potently inhibit the RAS/RAF/MEK/ERK signaling pathway. Mutational activation of RAS occurs in about 30 percent of all human tumors, including non-small cell lung, pancreatic, and colon ca...

  3. Drug

    Potassium sodium hydrogen citrate

    go.drugbank.com/drugs/DB16585
    Investigational

    Synonyms: Uralyt-UProducts: URALYT U, Uralyt U - Granulat
  4. Drug

    Carbazochrome sulfonic acid

    go.drugbank.com/drugs/DB15969
    Investigational

    Mixtures: HEMOSIN K, HEMOSIN-K
  5. Drug

    Potassium hydrogen DL-aspartate

    go.drugbank.com/drugs/DB15998
    Investigational

    Mixtures: Trommcardin K 120 - Infusionsflasche
  6. Drug

    Deslanoside

    go.drugbank.com/drugs/DB01078
    Approved

    Deacetyllanatoside C. A cardiotonic glycoside from the leaves of Digitalis lanata.

  7. Drug

    Trilaciclib

    go.drugbank.com/drugs/DB15442
    ApprovedInvestigational

    Trilaciclib, or G1T28, is a CDK4 and CDK6 inhibitor, indicated to reduce the incidence of chemotherapy induced myelosuppression in patients before topotecan-containing or platinum and etoposide-containing chemotherapy for extensive stage...

    Categories: MATE 2-K Inhibitors